MannKind Corp
MNKD
#6219
Rank
โ‚น88.53 B
Marketcap
โ‚น286.56
Share price
-1.00%
Change (1 day)
-25.05%
Change (1 year)

Revenue for MannKind Corp (MNKD)

Revenue in 2025 (TTM): โ‚น30.60 Billion

According to MannKind Corp's latest financial reports the company's current revenue (TTM ) is โ‚น33.78 Billion. an increase over the revenue in the year 2024 that were of โ‚น24.49 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for MannKind Corp from 2009 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น31.32 B27.9%
2024 โ‚น24.49 B47.87%
2023 โ‚น16.56 B100.62%
2022 โ‚น8.25 B47.03%
2021 โ‚น5.61 B17.86%
2020 โ‚น4.76 B5.98%
2019 โ‚น4.49 B130.77%
2018 โ‚น1.94 B159.75%
2017 โ‚น0.74 B-93.69%
2016 โ‚น11.87 B
2015 N/A
2014 N/A
2013 N/A-100%
2012 โ‚น1.91 M-27.55%
2011 โ‚น2.64 M-36.53%
2010 โ‚น4.16 M
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚น6.129 T 18,043.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚น4.973 T 14,622.95%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
โ‚น6.994 T 20,603.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น6.366 T 18,746.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚น135.20 B 300.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚น5.34 B-84.17%๐Ÿ‡บ๐Ÿ‡ธ USA